Latest Press Releases

Health News Posted on Saturday, December 14, 2024

Premium Press Releases »

At EuroEcho, Ebit (Esaote Group) Presents the World premiere of ZEfiRO, the new “cloud-native” PACS for the SUITESTENSA platform, Redefining its Design Philosophy

BERLIN and GENOA, Italy, Dec. 13, 2024 (GLOBE NEWSWIRE) -- EBIT s.r.l., the Esaote Group company that leads the Information Technology sector in the Healthcare field , is presenting the world premiere at EuroEcho (Berlin, December 11-13, ...

Read More

Patient Centricity in Pharma: Best Practices for Building Trust

Patient centricity is now recognized as one of the key values in the pharmaceutical business, changing both the research and development of new drugs as well as their clinical trials and treatment. For example, a recent Deloitte report revealed that ...

Read More

KFSHRC Jeddah Performs the First Fully Robotic Liver Transplant in the Western Region

JEDDAH, Saudi Arabia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) in Jeddah successfully performed the first robotic liver transplant in the Western Region on a 23-year-old man suffering from ...

Read More

WeightWatchers Unveils Next-Gen Program With AI-Powered App Features

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the launch of its innovative next-gen program, introducing advanced features designed to make weight management ...

Read More

CEPI and Accumulus Synergy Team up to Enhance Information Equity and Accelerate Access to Vaccines

OSLO, Norway and BURLINGAME, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health technologies by enabling multi-country regulatory ...

Read More

RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases

BENGALURU, India, Dec. 10, 2024 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a pioneering Bengaluru-based biotechnology company, has successfully closed its seed funding round backed by angel investors. This funding will ...

Read More

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, ...

Read More

Press Releases »

FDA Approves New Treatment for Congenital Adrenal Hyperplasia

PR Newswire SILVER SPRING, Md., Dec. 13, 2024 SILVER SPRING, Md., Dec. 13, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Crenessity (crinecerfont) to be used together with glucocorticoids (steroids) to control ...

Read More

Blood Market to Grow by USD 2.6 Billion (2024-2028), Report on AI-Driven Market Transformation and Growth in Hospitals and Blood Banks - Technavio

PR Newswire NEW YORK, Dec. 13, 2024 NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global blood market  size is estimated to grow by USD 2.60 billion from 2024-2028, according to Technavio. The ...

Read More

Experts Recommend Boosting Weekly Pulses Intake from 1.5 to 2.5 Cups, Recognizing Their Unique Role in Reducing Diet-Related Chronic Diseases

PR Newswire MOSCOW, Idaho, Dec. 13, 2024 Scientific Report Highlights Pulses – Beans, Peas, Lentils, and Chickpeas - as a Foundation of Healthy Eating MOSCOW, Idaho, Dec. 13, 2024 /PRNewswire/ -- USA Pulses - The Dietary Guidelines ...

Read More

Discovery Behavioral Health Expands Access to Substance Use Treatment through Optum Medicaid in Texas

PR Newswire LOS ANGELES, Dec. 13, 2024 LOS ANGELES, Dec. 13, 2024 /PRNewswire/ -- Discovery Behavioral Health, Inc., a national leader in measurement-informed care for eating disorders, mental health and substance use announced today that ...

Read More

InventHelp Inventor Develops Non-Invasive Urinary System for Men (SBT-1902)

PR Newswire PITTSBURGH, Dec. 13, 2024 PITTSBURGH, Dec. 13, 2024 /PRNewswire/ -- "I'm a registered nurse, and I was inspired while taking care of countless obese male patients with injuries that prevent them from moving in bed or being able ...

Read More

The Psychiatric Rehabilitation Association, University of Massachusetts Chan Medical School, and Meaningful Measurement, Inc. Collaborate to Develop Innovative Mobile Health App for Justice-Involved Individuals with Substance Use Disorder and Mental Health Issues

PR Newswire CHICAGO, Dec. 13, 2024 Partnership Aims to Support Recovery and Reduce Overdose Risks with "R-Assist" Mobile Health App. CHICAGO, Dec. 13, 2024 /PRNewswire/ -- The Psychiatric Rehabilitation Association (PRA), University of ...

Read More

InventHelp Inventor Develops Device to Magnify Small Print on Medicine Bottles (RSJ-200)

PR Newswire PITTSBURGH, Dec. 13, 2024   PITTSBURGH, Dec. 13, 2024 /PRNewswire/ -- "I wanted to create a simple device to magnify the small print on pill/medicine bottles," said an inventor, from Huntsville, Ala., "so I invented the ...

Read More

ACTION Centers Collaborate with Johnson & Johnson MedTech to Secure FDA Labeling for Impella Support System in Pediatric Patients

PR Newswire CINCINNATI, Dec. 13, 2024 CINCINNATI, Dec. 13, 2024 /PRNewswire/ -- In a groundbreaking achievement for pediatric heart care, the FDA has expanded the labeling of Johnson & Johnson MedTech's Impella Support System to include ...

Read More

InventHelp Inventor Develops New Product for Men to Absorb Urine Leakage (RKH-672)

PR Newswire PITTSBURGH, Dec. 13, 2024 PITTSBURGH, Dec. 13, 2024 /PRNewswire/ -- "My inspiration for creating this product came out of desperation while taking care of my father before he passed away. The main reason was so the urine will not ...

Read More

CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)

PR Newswire MARBURG, Germany, Dec. 13, 2024 If approved, garadacimab will be the first and only once-monthly treatment inhibiting factor XIIa to prevent attacks in HAE patients – a community CSL has been serving for more than 40 years ...

Read More

Patient Controlled Injectors Market Size Set for Explosive Growth, With Projections Indicating $ 12.33 billion by 2031 | The Insight Partners

PR Newswire NEW YORK, Dec. 13, 2024 The report from The Insight Partners lists several stakeholders—including healthcare providers, government agencies and health authorities, insurance providers, and academic and private research ...

Read More

Fusion Biopsy Market to Hit USD 0.91 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™

PR Newswire DELRAY BEACH, Fla., Dec. 13, 2024 DELRAY BEACH, Fla., Dec. 13, 2024 /PRNewswire/ -- The global fusion biopsy market is projected to grow at a compound annual growth rate (CAGR) of 7.1%, increasing from an estimated USD 0.65 ...

Read More

Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for TECENTRIQ SC (atezolizumab, solution for subcutaneous injection)

Canada NewsWire MISSISSAUGA, ON, Dec. 13, 2024 MISSISSAUGA, ON, Dec. 13, 2024 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) ...

Read More

Injury Board Partners with Children's Hospitals to Bring Comfort and Joy to Children with Rare Diseases

PR Newswire TAMPA, Fla., Dec. 13, 2024 TAMPA, Fla., Dec. 13, 2024 /PRNewswire/ -- Children with rare diseases face not only medical challenges but also the emotional toll of lengthy and complex treatments. Injury Board is proud to partner ...

Read More

Lumicell Announces Poster Presentations at the 2024 San Antonio Breast Cancer Symposium Focused on Patient Benefit of Using LumiSystem™ During Lumpectomy

PR Newswire NEWTON, Mass., Dec. 13, 2024 New data suggests that patients were satisfied with their cosmetic outcomes following the removal of suspicious tissue detected by fluorescence-guided imaging during lumpectomy surgery, and prefer to ...

Read More

Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease

PR Newswire INDIANAPOLIS, Dec. 13, 2024 The Phase 3 VIVID-1 trial evaluated the safety and efficacy of Omvoh in patients with or without prior biologic failure and was the basis for the positive opinion  VIVID-1 was the first pivotal ...

Read More

Marengo to Present Clinical Data Highlighting Invikafusp Alfa (STAR0602), a First-in-Class Selective, Dual T Cell Agonist at ESMO Immuno-Oncology Congress 2024

PR Newswire CAMBRIDGE, Mass., Dec. 13, 2024 — Results further validate company's novel and proprietary STAR bi-specific antibody platform for selective T cell activation in vivo — CAMBRIDGE, Mass., Dec. 13, 2024 /PRNewswire/ -- Marengo ...

Read More

Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement

PR Newswire WARSAW, Ind., Dec. 13, 2024 New Anatomically Shaped Asymmetric Stemless Design for Total Shoulder Replacement WARSAW, Ind., Dec. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical ...

Read More

Baby Diapers Market size to increase by USD 22.5 Billion between 2023 to 2028, Market Segmentation by Product, Distribution Channel, Geography, Technavio

PR Newswire NEW YORK, Dec. 13, 2024 NEW YORK, Dec. 13, 2024 /PRNewswire/ -- The global baby diapers market size is estimated to grow by USD 22.5 billion from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of ...

Read More

Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends - Technavio

PR Newswire NEW YORK, Dec. 13, 2024 NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global fitness app market size is estimated to grow by USD 55.86 billion from 2024-2028, according to ...

Read More

Ewing's Sarcoma Treatment Market to Grow by USD 205.09 Million (2024-2028), Awareness and Funding Drive Growth, AI-Powered Report on Market Trends - Technavio

PR Newswire NEW YORK, Dec. 13, 2024 NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global ewing's sarcoma treatment market size is estimated to grow by USD 205.09 million from 2024-2028, ...

Read More

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

PR Newswire NEW YORK and SUZHOU, China, Dec. 12, 2024 NEW YORK and SUZHOU, China, Dec. 12, 2024 /PRNewswire/ -- Accropeutics Inc. (Accropeutics), a clinical-stage biotech company with a focus on molecular mechanisms of regulated cell death ...

Read More

Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS

PR Newswire PRINCETON, N.J. and SUZHOU, China, Dec. 12, 2024 PRINCETON, N.J. and SUZHOU, China, Dec. 12, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharmaceutical company with ...

Read More

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

PR Newswire YANTAI, China, Dec. 12, 2024 YANTAI, China, Dec. 12, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium ...

Read More

Study shows American College of Lifestyle Medicine education initiative improves clinicians' ability to make lifestyle and dietary interventions

PR Newswire ST. LOUIS, Dec. 12, 2024 The complimentary CME/CE "Lifestyle Medicine and Food as Medicine Essentials" online course was offered in support of the 2022 White House Conference on Hunger, Nutrition and Health. More than 53,000 ...

Read More

Roswell Park Team Identifies Factors That Boost Effectiveness of Immunotherapy in Recurrent Ovarian Cancer

PR Newswire BUFFALO, N.Y., Dec. 12, 2024 A study led by Roswell Park provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian ...

Read More

XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.

PR Newswire ATLANTA, Dec. 12, 2024 Xstrahl's XBeam has received FDA 510(k) Clearance for Use in the U.S. XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, ...

Read More

Marin, Barrett, and Murphy: Helping Rhode Islanders Harmed by PFAS Chemicals Found in Local Drinking Water

PR Newswire CRANSTON, R.I., Dec. 12, 2024 CRANSTON, R.I., Dec. 12, 2024 /PRNewswire/ -- Marin, Barrett, and Murphy, a leading Rhode Island law firm, is now accepting clients harmed by PFAS (per- and polyfluoroalkyl substances) contamination ...

Read More

Diverse Virus Populations Coexist on Single Strains of Gut Bacteria

PR Newswire NEW YORK, Dec. 12, 2024 Viral "Social Lives" Key to Developing Treatments for Bacterial Infections NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Viruses that infect and kill bacteria, called phages, hold promise as new treatment ...

Read More

Researchers at Medical College of Wisconsin Advance Treatments for Hip, Knee Replacements

PR Newswire MILWAUKEE, Dec. 12, 2024 MR imaging technology developed with GE HealthCare has the potential to improve imaging metal implants that may enable earlier detection of implant failure MILWAUKEE, Dec. 12, 2024 /PRNewswire/ ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.